Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics Evaluation and Research, was linked to his advocacy for vaccines ...

Mary Burke and Colm Moules present Gavin Enright with the Ernie Sharp Cup for the best agricultural/horticultural display at the Arklow St Patrick's Day parade awards ...

Thousands of FDA workers lost their jobs this week. The most prominent was Peter Marks, director of the agency’s Center for Biologics Evaluation and Research (CBER). While this position has been ...

MAKARY OK’D MARKS OUSTER — The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine regulator Dr. Peter Marks, openly worrying ...

You can reach Jason on Signal at JasonMast.05. Peter Marks, the top Food and Drug Administration official who oversaw vaccines, gene therapies, and the blood supply, resigned Friday after being ...

“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industr ...

That's according to reporting from Politico, which details the deliberations that led to the departure of Peter Marks, M.D., Ph.D., the former leader of the agency's Center for Biologics ...

The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for Biologics Evaluation and Research, has sent reverberations throughout ...

On Friday, Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for Biologics Evaluation and Research) citing differences with ...

Newly sworn-in Food and Drug Administration (FDA) Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his first acts as chief ...

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.

Peter Marks, the Food and Drug Administration’s top vaccine official, abruptly resigned from the agency on Friday, citing disagreement with Health and Human Services Secretary Robert F. Kennedy Jr.